Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening

Authors:

Abstract
Significance: The optimal timing of surgery/chemotherapy and the benefits of earlier diagnosis of HGSC remain controversial. We developed a mathematical framework of tumor dynamics, populated the model with primary clinical data, and reliably recapitulated clinical observations. Our model predicts that 1) PDS is superior to NACT with relatively small tumor burden and when complete debulking is feasible, 2) timely adjuvant chemotherapy is critical for the outcome of PDS with <1-mm residual tumors, 3) earlier detection of relapse is unlikely beneficial with current therapies, and 4) earlier detection of primary HGSC could have substantial benefit. These results provide insights into the evolutionary dynamics of HGSC, argue for new clinical trials to optimize therapy, and are potentially applicable to other tumor types.
All Related Versions
Funding Information
  • Terry Fox Foundation (TFPPG 020003)
  • HHS | NIH | National Cancer Institute (R37 49152)
  • HHS | NIH | National Cancer Institute (R01257507)
  • Mary Kay Ash Foundation (XXX)
  • Sara Elizabeth O'Brien Trust (XXX)
  • University of Toronto (DCA Award)
  • HHS | NIH | National Cancer Institute (P30 CA008748)
  • Ontario Ministry of Health and Long-Term Care (XXX)
  • Princess Margaret Cancer Foundation (XXX)

This publication has 79 references indexed in Scilit: